Canada Markets open in 7 hrs 36 mins

Abeona Therapeutics Inc. (ABEO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2513-0.0053 (-2.07%)
At close: 04:00PM EST
0.2515 +0.00 (+0.08%)
After hours: 07:35PM EST
Currency in USD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.42
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.7900
52 Week Low 30.2500
50-Day Moving Average 30.5274
200-Day Moving Average 31.1436

Share Statistics

Avg Vol (3 month) 33.1M
Avg Vol (10 day) 32.98M
Shares Outstanding 5146.62M
Implied Shares Outstanding 6N/A
Float 894.54M
% Held by Insiders 115.60%
% Held by Institutions 125.96%
Shares Short (Dec. 14, 2021) 41.34M
Short Ratio (Dec. 14, 2021) 41.41
Short % of Float (Dec. 14, 2021) 41.53%
Short % of Shares Outstanding (Dec. 14, 2021) 41.32%
Shares Short (prior month Nov. 14, 2021) 42.11M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Oct. 23, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec. 30, 2020
Most Recent Quarter (mrq)Sep. 29, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,922.13%

Management Effectiveness

Return on Assets (ttm)-25.89%
Return on Equity (ttm)-55.51%

Income Statement

Revenue (ttm)3M
Revenue Per Share (ttm)0.03
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-20.14M
EBITDA -54.38M
Net Income Avi to Common (ttm)-54.08M
Diluted EPS (ttm)-0.5670
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)67M
Total Cash Per Share (mrq)0.66
Total Debt (mrq)6.17M
Total Debt/Equity (mrq)7.73
Current Ratio (mrq)2.57
Book Value Per Share (mrq)0.78

Cash Flow Statement

Operating Cash Flow (ttm)-37.02M
Levered Free Cash Flow (ttm)-27.07M